Preoperative Inspiratory Muscle Training in Esophageal Resection (PREPARE)

May 10, 2017 updated by: Frank JG Backx, MD PhD, UMC Utrecht

Preoperative Inspiratory Muscle Training to Prevent Postoperative Pneumonia in Patients Undergoing Esophageal Resection

The PREPARE study is the first multicenter randomized controlled trial to evaluate the hypothesis that preoperative inspiratory muscle training leads to decreased pulmonary complications in patients undergoing esophageal resection.

Study Overview

Status

Completed

Detailed Description

Rationale: Esophageal resection is associated with high incidences of postoperative pulmonary pneumonia. Numbers of 30% are reported in literature. Postoperative complications can result in prolonged hospital stay and increased health care costs. In cardiac surgery patients a reduction of postoperative pneumonia of 50% is reported as a result of a preoperative inspiratory muscle training program. While in some surgical centers IMT is already used in the preoperative phase in patients undergoing esophageal resection, the effect of this promising intervention has not yet been investigated in a randomised and controlled study design in large surgical populations other than cardiac surgery.

Primary objective: Investigate the effect of a preoperative inspiratory muscle training program on the incidence of postoperative pneumonia in patients undergoing esophageal resection.

Study design: Prospective multicenter randomised controlled clinical trial.

Main study parameters/endpoints: A significant reduction in incidence of postoperative pneumonia.

Study Type

Interventional

Enrollment (Actual)

245

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leuven, Belgium
        • University Hospital Gasthuisberg
      • Helsinki, Finland
        • HUS
      • Dublin, Ireland
        • St. James's Hospital
      • Almelo, Netherlands
        • Zorggroep Twente
      • Amsterdam, Netherlands
        • VU Medical Center
      • Delft, Netherlands
        • Reinier de Graaf Gasthuis
      • Heerlen, Netherlands
        • Atrium Medical Center
      • Nijmegen, Netherlands
        • Canisius Wilhelmina Hospital
      • Utrecht, Netherlands
        • UMC Utrecht

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • (Cognitively) capable to understand and perform a preoperative IMT program
  • Surgery is scheduled at least 2 weeks after signing informed consent, since the patients need to be able to follow the intervention program for at least 2 weeks
  • Willing to sign the informed consent form

Exclusion Criteria:

  • Unable to communicate in Dutch language
  • Age < 18 years
  • Participating in a conflicting trial concerning esophageal resection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Usual care + Inspiratory Muscle Training (IMT)

The IMT protocol is tailored individually. Inspiratory load is set at 60% of the measured maximal inspiratory pressure (Pimax). The load is incrementally increased based on the rate of perceived exertion (RPE) scored on a scale from 0 to 10 which is scored by the patient after each training session. When patients score an RPE below 7, patients increase the inspiratory load of the threshold device with 5% to guarantee overload during each training session. Patients have to complete 30 dynamic inspiratory efforts twice daily.

Patients will be instructed to train at home 7 days a week until surgery with a minimum of 2 weeks.

Training will be started after the chemoradiation period (if applicable).

No Intervention: Usual care (no IMT)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pneumonia incidence
Time Frame: Date of first pneumonia event. Participants will be followed for the duration of hospital stay, an expected average of 2 weeks
Pneumonia will be scored according to the Utrecht Pneumonia Scoring System.
Date of first pneumonia event. Participants will be followed for the duration of hospital stay, an expected average of 2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of stay
Time Frame: Time between date of surgery and first discharge from ICU and first discharge from hospital (on average 14 days)
Postoperative length of stay on the intensive care unit, Postoperative length of hospital stay.
Time between date of surgery and first discharge from ICU and first discharge from hospital (on average 14 days)
Duration of mechanical ventilation
Time Frame: Time between intubation and first extubation (in general no more then 24 hours)
Number of hours spent on the mechanical ventilator during and directly following the primary surgery.
Time between intubation and first extubation (in general no more then 24 hours)
Respiratory muscle function
Time Frame: At baseline, before surgery and 3, 6 and 9 days after surgery.
Inspiratory muscle endurance and maximal inspiratory pressure at the mouth (Pi-max).
At baseline, before surgery and 3, 6 and 9 days after surgery.
Pulmonary function
Time Frame: At baseline, before surgery and 3, 6 and 9 days after surgery.
Forced Expiratory Volume in one second (FEV1), Forced vital capacity (FVC), FEV1/FVC ratio.
At baseline, before surgery and 3, 6 and 9 days after surgery.
Quality of life
Time Frame: At baseline and 4 weeks after surgery
Quality of life is measured using the EuroQol and SF-12 questionnaires.
At baseline and 4 weeks after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2013

Primary Completion (Actual)

July 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

June 17, 2013

First Submitted That Met QC Criteria

July 1, 2013

First Posted (Estimate)

July 8, 2013

Study Record Updates

Last Update Posted (Actual)

May 11, 2017

Last Update Submitted That Met QC Criteria

May 10, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • NL43194.041.13

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Esophageal Resection Candidates

Clinical Trials on Inspiratory Muscle Training (IMT)

3
Subscribe